Option chain shows key data for IM Cannabis's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for IM Cannabis.

IM Cannabis (NASDAQ:IMCC) Stock, Option Chain

IM Cannabis

IM Cannabis Corp is a Canada-based international medical cannabis company. It operates in the field of medical cannabis, through Focus Medical Herbs Ltd. (Focus), which holds a cultivation license to breed, grow, and supply medical cannabis products The majority of its revenues are generated from sales of medical cannabis products to customers in Israel. The remaining revenues are generated from sales of medical cannabis, as well as other products, to customers in Germany. Geographically, the majority is from Israel.

elsa-olofsson-12-Zs1xIEtA-unsplash(23)

Cannabis

Earnings

News

Eurozone

CSE:IMCC

IMCC

International medical cannabis company IM Cannabis Corp. (NASDAQ: IMCC) (CSE: IMCC) announced on Thursday its financial results for the third quarter ended Sept. 30, 2024. The company reported revenue from Germany grew 66% year-over-year, reaching CA$5.8 million ($4.1 million). &#34;While the 66% growth we delivered in Germany, to reach $5.8M this quarter is a highlight, we spent the quarter focused on building a solid foundation for 2025,&#34; Oren Shuster, the company&#39;s CEO, said. &#34;Our goal was to build a strong, consistent supply chain, along with a laser focus on how to improve the efficiency and accuracy of how we use our resources. I believe that the foundation we built this quarter will be the basis we will use to deliver in 2025.&#34;

IM Cannabis: 66% Revenue Growth In Germany, Narrows EBITDA Loss In Q3

pexels-kindelmedia-7668047(1)

CANNABIS WHEATON INCOME by Cannabis Wheaton Income Corp.

CBWTF

TSX:WEED

TSX:XLY

WEED

Select Sector SPDR-Consumer Discretionary

Canopy Growth Corporation (TSX: WEED) (NASDAQ: CGC) will report the second quarter of fiscal year 2025 ended Sept. 30, before financial markets open on Friday, Nov. 8, 2024. IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) a medical cannabis company with operations in Israel and Germany, will report operational and financial results for the third quarter ended Sept. 30 on Nov. 14, 2024, before the market opens. Auxly Cannabis Group Inc. (TSX: XLY) (OTCQB: CBWTF) will report earnings results for its third quarter ended Sept. 30 on Friday, Nov. 8, 2024, before the financial markets open.

Canopy Growth And Other Top Cannabis Companies To Report Earnings: Will Results Get Pot Stocks On Track Following Post-Election Dip?

ben-rosett-WdJkXFQ4VHY-unsplash(1)

Entrepreneurship

Movers & Shakers

AYRWF

CRLBF

CSE:AYR

CSE:CL

CSE:OILS

EDXC

FLGC

OILFF

ROMJF

SNDL

TILT

TLLTF

TSX:ACB

TSX:ROMJ

TSXV:ROMJ

The U.S. Hemp Roundtable made headlines in early September as its board of directors welcomed two distinguished leaders from the hemp beverage sector to its officer ranks. New York&#39;s chief equity officer at the state Office of Cannabis Management, Damian Fagon, has formally resigned, effective November 27.

The Ever-Evolving Cannabis Industry: These Are Latest Leadership Changes You Should Know About

IM Cannabis Corp

IM Cannabis Corp (TSE:IMCC) has released an update. IM Cannabis Corp. has announced a planned private placement offering aimed at raising up to US$...

IM Cannabis Corp. Plans Private Placement and Restructures Incentives

Tilray Q1 Preview: Germany Could Drive Earnings Surprise

IM Cannabis Corp (TSE:IMCC) has released an update. IM Cannabis Corp reported a significant 50% increase in revenue in its German subsidiary follow...

IM Cannabis Corp: Revenue Surge and Expansion Plans

IM Cannabis Corp (TSE:IMCC) has released an update. IM Cannabis Corp., a prominent player in the medical cannabis market in Israel and Germany, is ...

IM Cannabis to Announce Q3 2024 Financial Results

IM Cannabis Corp (TSE:IMCC) has released an update. IM Cannabis Corp reported a 12% increase in revenue and a 16% reduction in operating expenses f...

IM Cannabis Reports Revenue Growth and Efficiency Gains

IM Cannabis GAAP EPS of -$0.41, revenue of $13.9M

IM Cannabis Corp. (IMCC) Q3 2024 Earnings Call Transcript

IM Cannabis Corp. 2024 Q3 - Results - Earnings Call Presentation

In this week's "Rising High," The Fly's recurring series focused on cannabis and psychedelic stock news, The Fly looks back on earnings, a Phase 3 ...

Rising High: Cannabis firms report quarterly earnings

IM Cannabis Corp (TSE:IMCC) has released an update. IM Cannabis Corp has closed a non-brokered private placement offering, raising over C$2 million...

IM Cannabis Corp Raises Funds Amid Global Challenges

AAWH

ATAI

CANN

CMPS

CRON

CVSI

CYBN

ENVB

GRWG

MEDIF

NLCP

RLMD

SHFS

TCNNF

TLRY

VREOF

Press Releases

IM Cannabis Receives NASDAQ Notification of Regaining Compliance with Nasdaq's Minimum Bid Price Requirement

IM Cannabis to Report Second Quarter 2024 Financial Results on Wednesday, August 14th at 9:00am ET

IM Cannabis Reports Second Quarter Financial Results

Small Cap

IM Cannabis Announces Appointment of Shmulik Arbel to Board of Directors

Mutual Funds

Markets

IMC Germany Announces Outstanding Preliminary Q3, 2024 Performance with 50% Growth Over Q2

Offerings

IM Cannabis Announces up to US$1,613,000 Private Placement Offering Led by Management

IM Cannabis to Report Third Quarter 2024 Financial Results on Thursday, November 14th at 9:00am ET

IM Cannabis Closes Non-Brokered Private Placement led by Management and Concurrent Debt Settlement

IM Cannabis Reports Third Quarter Financial Results

Comments

IM Cannabis

IM Cannabis (IMCC) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga